Article citationsMore>>

A. H. Liliana, E. Inga, B. Lars, D. Gunnar, A. H. Lars and M. Inger, “Human Lactoferrin and Peptides Derived from a Surface-Exposed Helical Region Reduce Experimental Escherichia coli Urinary Tract Infection in Mice,” Infection and Immunity, Vol. 68, No. 10, 2000, pp. 5816-5823.

has been cited by the following article:

• TITLE: Studies on the Immunomodulatory Effects of Lactoferrin in Rats Infected with E. coli

  AUTHORS: Mohamed El-Sayed El-Boshy, Osama Ali Abdalla, Adal Hassan

  KEYWORDS: Lactoferrin; Immunomodulatory; E coli; Rats

  JOURNAL NAME: Journal of Immune Based Therapies, Vaccines and Antimicrobials, Vol.2 No.4, October 9, 2013

  ABSTRACT: Eighty male albino rats of Westar strain (350 ± 10 g), 10 to 12 weeks old were divided into four groups. The groups treated are as following. The first control group (Gp. I) was given intraperitoneally in normal saline (1 mL). The second group (Gp. II) was orally infected with 3 × 1012 CFU of E. coli /Kg. BW. The third group (Gp. III) was infected with E. coli and treated with (0.5%) lactoferrin (LF) 72 hours before E. coli infection in filtered tap water for the duration of the experiment (21 days). The fourth group (Gp. IV) was administrated with LF only (0.5%) in drinking water. Two separate blood samples were collected from heart puncture at the end of 1st, and 3rd week post-treatment for immunological studies. The Leukogram in E. coli treated group was insignificant compared with the control group while lymphocytosis was clear compared with the infected group. Total protein, albumin, α-globulin and β-globulin were insignificantly